Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection

Journal of Reproductive Immunology

Volumn 84, Issue 1, 2010, Pages 8-15

  Johnson, Alison J ^a   Nelson, Michelle H ^a   Bird, Melanie D ^a   Chu, Chin Fun ^a   Milligan, Gregg N ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Antibody; Female genital tract; HSV 2; IFN ; IL 17; Sensory ganglia

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 4; THYMIDINE KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FEMALE GENITAL SYSTEM; GENE EXPRESSION; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMORAL IMMUNITY; INFECTION RESISTANCE; MOUSE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SENSORY GANGLION; SPINAL GANGLION; T LYMPHOCYTE ACTIVATION; VIRUS NEUTRALIZATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; THYMIDINE KINASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73149123781     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.09.007     Document Type: Article

References (39)

1. Ashkar A.A., and Rosenthal K.L. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77 (2003) 10168-10171
2. + T cell homeostasis by perforin and interferon-gamma. Science 290 (2001) 1354-1358
3. Bird M.D., Chu C.-F., Johnson A.J., and Milligan G.N. Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon. J. Virol. 81 (2007) 423-426
4. Bouley D.M., Kanangat S., Wire W., and Rouse B.T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFNγ knockout mice. J. Immunol. 155 (1995) 3964-3971
5. Chu C.-F., Meador J.G., Young C.G., Strasser J.E., Bourne N., and Milligan G.N. Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms. J. Reprod. Immunol. 78 (2008) 58-67
6. Corey L., Wald S., Celum C.L., and Quinn T.C. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 35 (2004) 435-445
7. Dix R.D., Pereira L., and Baringer J.R. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect. Immun. 34 (1981) 192-199
8. + T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J. Virol. 79 (2005) 14545-14554
9. Dudley K.L., Bourne N., and Milligan G.N. Immune protection against HSV-2 in B-cell-deficient mice. Virology 270 (2000) 454-463
10. Harandi A.M., Svennerholm B., Holmgren J.H., and Eriksson K. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol. 75 (2001) 6705-6709
11. Harandi A.M., Svennerholm B., Holmgren J., and Eriksson K. Differential roles of B cells and IFNgamma-secreting CD4 (+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82 (2001) 845-853
12. Ijima N., Linehan M.M., Zamora M., Butkus D., Dunn R., Kehry M.R., et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. 205 (2008) 3041-3052
13. Ito M., and O-Malley J.A. Antiviral effects of recombinant human tumor necrosis factor. Lymphokine Res. 6 (1987) 309-318
14. + T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J. Virol. 82 (2008) 9678-9688
15. Kaushic C., Ashkar A.A., Reid L.A., and Rosenthal K.L. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J. Virol. 77 (2003) 4558-4565
16. Koelle D.M., Posavad C.M., Barnum G.R., Johnson M.L., Frank J.M., and Corey L. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101 (1998) 1500-1508
17. Kohl S., Strynadka N.C.J., Hodges R.S., and Pereira L. Analysis of the role of antibody-dependent cellular cytotoxicity antibody activity in murine neonatal herpes simplex virus infection with anti bodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J. Clin. Invest. 86 (1990) 273-278
18. Kuklin N.A., Daheshia M., Chun S., and Rouse B.T. Role of mucosal immunity in herpes simplex virus infection. J. Immunol. 160 (1998) 5998-6003
19. Linehan M.M., Richman S., Krummenacher C., Eissenberg R.J., Cohen G.H., and Iwasaki A. In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa. J. Virol. 78 (2004) 2530-2536
20. McDermott M.R., Smiley J.R., Leslie P., Brais J., Rudzroga H.E., and Bienenstock J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51 (1984) 747-753
21. Mikloska Z., and Cunningham A.L. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 75 (2001) 11821-11826
22. Milligan G.N., and Bernstein D.I. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212 (1995) 481-489
23. Milligan G.N., and Bernstein D.I. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229 (1997) 259-268
24. Milligan G.N., Bernstein D.I., and Bourne N. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160 (1998) 6093-6100
25. Milligan G.N., Bourne N., and Dudley K.L. Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina. J. Reprod. Immunol. 49 (2001) 49-65
26. Milligan G.N., Dudley-McClain K.L., Young C.G., and Chu C.-F. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice. J. Reprod. Immunol. 61 (2004) 115-127
27. Parr E.L., and Parr M.B. Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2. J. Virol. 72 (1998) 5137-5145
28. Parr M.B., and Parr E.L. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258 (1999) 282-294
29. Pierce A.T., DeSalvo J., Foster T.P., Kosinski A., Weller S.K., and Halford W.P. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J. Gen. Virol. 86 (2005) 2421-2432
30. + cytotoxic T lymphocyte responses. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10289-10294
31. Rossol-Voth R., Rossol S., Schutt K.H., de Cian W., and Falke D. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72 (1991) 143-147
32. Sainz Jr. B., and Halford W.P. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76 (2002) 11541-11550
33. Smith P.M., Wolcott R.M., Chervenak R., and Jennings S.R. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ. Virology 202 (1994) 76-88
34. Tsunobuchi H., Hishimura H., Goshima F., Daikoku T., Suzuki H., Nakashima I., et al. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology 275 (2000) 57-66
35. Tumpey T.M., Chen S.H., Oakes J.E., and Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70 (1996) 898-904
36. Wald A., and Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 18 (2002) 45-52
37. Wald A., Zeh J., Selke S., Warren T., Ryncarz A.J., Ashley, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342 (2000) 844-850
38. Yu A., Manickan E., and Rouse B.T. Role of interferon-γ in immunity to herpes simplex virus. J. Leuk. Biol. 60 (1996) 528-532
39. + T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 204 (2007) 595-603